Perbedaan Kadar Interferon Gamma Cairan Asites Pada Subtipe Histopatologi Serosa dan Non-Serosa Kanker Ovarium Tipe Epitel
Anindita Kurniasari(1*), Moh Nailul Fahmi(2), Nungki Anggorowati(3)
(1) Mahasiswa Program Sarjana Kedokteran, FK-KMK, UGM
(2) Departemen Obstetri dan Ginekologi, FK-KMK, UGM
(3) Departemen Patologi Anatomi FKKMK UGM
(*) Corresponding Author
Abstract
Latar Belakang: Karsinoma ovarium dapat dibedakan menjadi subtipe serosa dan non-serosa, dimana subtipe serosa memiliki prognosis yang lebih baik. IFN-γ dapat memiliki aktivitas pro-tumor maupun anti-tumor. Penelitian tentang kadar IFN-γ asites serta hubungannya dengan subtipe serosa dan non-serosa belum banyak dilakukan.
Tujuan: Mengetahui perbedaan rata-rata kadar IFN-γ cairan asites pada subtipe serosa dan non-serosa karsinoma ovarium.
Metode: Penelitian cross sectional selama periode September – Desember 2018. Pengambilan sampel asites dilakukan di kamar operasi RSUP Dr. Sardjito dan pengujian sitokin menggunakan Human IFN-γ ELISA Kit dilakukan di Laboratorium Biologi Molekuler FKKMK Universitas Gadjah Mada.
Hasil dan Pembahasan: Pada 11 sampel subtipe serosa didapatkan rata-rata kadar IFN-γ sebesar 0,46 pg/ml, sedangkan pada 7 sampel non-serosa didapatkan rata-rata 0,97 pg/ml, namun perbedaan rata-rata tersebut tidak signifikan secara statistik (p=0,104).
Simpulan: Tidak terdapat perbedaan rata-rata kadar IFN-γ dalam cairan asites pada subtipe serosa dan non-serosa karsinoma ovarium.
Kata Kunci: interferon gamma (IFN-γ), karsinoma ovarium, asites, subtipe histopatologi
Keywords
Full Text:
PDFReferences
- Marth, C., Fiegl, H., Zeimet, A.G., Müller-Holzner, E., Deibl, M., Doppler, W. and Daxenbichler, G., 2004. Interferon-γ expression is an independent prognostic factor in ovarian cancer. American journal of obstetrics and gynecology, 191(5), pp.1598-1605.
- American Cancer Society 2018, Key Statistics for Ovarian Cancer, Atlanta: American Cancer Society, Inc. 2018, viewed 21 April 2018, https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html
- World Health Organization 2014, Cancer Country Profiles, viewed 21 April 2018, https://www.who.int/cancer/country-profiles/idn_en.pdf
- Ezzati, M., Abdullah, A., Shariftabrizi, A., Hou, J., Kopf, M., Stedman, J.K., Samuelson, R. and Shahabi, S., 2014. Recent advancements in prognostic factors of epithelial ovarian carcinoma. International scholarly research notices, 2014.
- Reid, B.M., Permuth, J.B. and Sellers, T.A., 2017. Epidemiology of ovarian cancer: a review. Cancer biology & medicine, 14(1), p.9.
- World Health Organization, 2014. WHO Classification of Tumors of Female Reproductive Organs. 4th Edition, p.15-40.
- Mizuno, M., Kajiyama, H., Shibata, K., Mizuno, K., Kawai, M., Nagasaka, T. and Kikkawa, F., 2015. Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients. British journal of cancer, 112(8), p.1376.
- Ahmed, N. and Stenvers, K., 2013. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Frontiers in oncology, 3, p.256.
- Chen, Y.L., Cheng, W.F., Chang, M.C., Lin, H.W., Huang, C.T., Chien, C.L. and Chen, C.A., 2013. Interferon gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma. Gynecologic oncology, 131(1), pp.63-68.
- Hosono, S., Kajiyama, H., Mizuno, K., Sakakibara, K., Matsuzawa, K., Takeda, A., Kawai, M., Nagasaka, T. and Kikkawa, F., 2011. Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery. International journal of clinical oncology, 16(5), p.524.
- Mojic, M., Takeda, K. and Hayakawa, Y., 2017. The dark side of IFN-γ: its role in promoting cancer immunoevasion. International journal of molecular sciences, 19(1), p.89.
- Alspach, E., Lussier, D.M. and Schreiber, R.D., 2018. Interferon γ and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity. Cold Spring Harbor perspectives in biology, p.a028480.
- Ricci, F., Affatato, R., Carrassa, L. and Damia, G., 2018. Recent insights into mucinous ovarian carcinoma. International journal of molecular sciences, 19(6), p.1569.
- Ku, F.C., Wu, R.C., Yang, L.Y., Tang, Y.H., Chang, W.Y., Yang, J.E., Wang, C.C., Jung, S.M., Lin, C.T., Chang, T.C. and Chao, A., 2018. Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study. Journal of the Formosan Medical Association, 117(2), pp.117-125.
- Tan, D.S. and Kaye, S., 2007. Ovarian clear cell adenocarcinoma: a continuing enigma. Journal of clinical pathology, 60(4), pp.355-360.
DOI: https://doi.org/10.22146/jkr.44182
Article Metrics
Abstract views : 2738 | views : 2746Refbacks
- There are currently no refbacks.
Copyright (c) 2019 The Author(s)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
SEKRETARIAT JURNAL KESEHATAN REPRODUKSI
Departemen Obstetri dan Ginekologi, FK-KMK, UGM/RS Dr. Sardjito
Jl. Kesehatan No. 1, Sekip Utara, Yogyakarta 55281
Tlp: (0274) 511329 / Faks: (0274) 544003
Email: jurnal.kesehatanreproduksi@ugm.ac.id
Cp: Dwi Astuti +6281802698043